Titre : Inconduite professionnelle

Inconduite professionnelle : Questions médicales fréquentes

Termes MeSH sélectionnés :

Sample Size
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Inconduite professionnelle : Questions médicales les plus fréquentes", "headline": "Inconduite professionnelle : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Inconduite professionnelle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-17", "dateModified": "2025-03-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Inconduite professionnelle" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Éthique", "url": "https://questionsmedicales.fr/mesh/D004989", "about": { "@type": "MedicalCondition", "name": "Éthique", "code": { "@type": "MedicalCode", "code": "D004989", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.350" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inconduite scientifique", "alternateName": "Scientific Misconduct", "url": "https://questionsmedicales.fr/mesh/D015871", "about": { "@type": "MedicalCondition", "name": "Inconduite scientifique", "code": { "@type": "MedicalCode", "code": "D015871", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N05.350.979.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Inconduite professionnelle", "alternateName": "Professional Misconduct", "code": { "@type": "MedicalCode", "code": "D028743", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Charles Piller", "url": "https://questionsmedicales.fr/author/Charles%20Piller", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Shokoh Varaei", "url": "https://questionsmedicales.fr/author/Shokoh%20Varaei", "affiliation": { "@type": "Organization", "name": "School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran." } }, { "@type": "Person", "name": "Nahid Dehghan Nayeri", "url": "https://questionsmedicales.fr/author/Nahid%20Dehghan%20Nayeri", "affiliation": { "@type": "Organization", "name": "Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran." } }, { "@type": "Person", "name": "Leila Sayadi", "url": "https://questionsmedicales.fr/author/Leila%20Sayadi", "affiliation": { "@type": "Organization", "name": "School of nursing & midwifery, Nursing and Midwifery Care Research Center, Tehran University of Medical Sciences, Tehran, Iran." } }, { "@type": "Person", "name": "Akram Ghobadi", "url": "https://questionsmedicales.fr/author/Akram%20Ghobadi", "affiliation": { "@type": "Organization", "name": "School of Nursing and Midwifery, Kermanshah University of Medical Sciences, Kermanshah, Iran. ghobadi_a57@yahoo.com." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Sample size considerations for micro-randomized trials with binary proximal outcomes.", "datePublished": "2023-04-24", "url": "https://questionsmedicales.fr/article/37094566", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/sim.9748" } }, { "@type": "ScholarlyArticle", "name": "Average nucleotide diversity should be weighted by per-site sample size.", "datePublished": "2022-11-24", "url": "https://questionsmedicales.fr/article/36377254", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/1755-0998.13738" } }, { "@type": "ScholarlyArticle", "name": "Sample size recalculation based on the prevalence in a randomized test-treatment study.", "datePublished": "2022-07-25", "url": "https://questionsmedicales.fr/article/35879675", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12874-022-01678-7" } }, { "@type": "ScholarlyArticle", "name": "Matching ratio and sample size for optimal sequential testing with binomial data.", "datePublished": "2023-06-06", "url": "https://questionsmedicales.fr/article/37278182", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/09622802231176031" } }, { "@type": "ScholarlyArticle", "name": "Sample Size and Estimation of Standard Radiation Doses for Pediatric Brain CT.", "datePublished": "2022-10-01", "url": "https://questionsmedicales.fr/article/36287806", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/tomography8050207" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Qualité, accès, évaluation des soins de santé", "item": "https://questionsmedicales.fr/mesh/D017530" }, { "@type": "ListItem", "position": 3, "name": "Éthique", "item": "https://questionsmedicales.fr/mesh/D004989" }, { "@type": "ListItem", "position": 4, "name": "Inconduite professionnelle", "item": "https://questionsmedicales.fr/mesh/D028743" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Inconduite professionnelle - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Inconduite professionnelle", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Inconduite professionnelle", "description": "Comment identifier l'inconduite professionnelle ?\nQuels signes indiquent une inconduite ?\nQui peut signaler une inconduite ?\nQuels outils aident au diagnostic ?\nQuelles sont les conséquences d'un diagnostic tardif ?", "url": "https://questionsmedicales.fr/mesh/D028743?mesh_terms=Sample+Size&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Inconduite professionnelle", "description": "Quels symptômes peuvent alerter sur une inconduite ?\nComment les patients réagissent-ils à l'inconduite ?\nQuels effets psychologiques l'inconduite a-t-elle ?\nY a-t-il des signes de stress chez le professionnel ?\nComment l'inconduite affecte-t-elle l'équipe médicale ?", "url": "https://questionsmedicales.fr/mesh/D028743?mesh_terms=Sample+Size&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Inconduite professionnelle", "description": "Comment prévenir l'inconduite professionnelle ?\nQuel rôle joue la supervision dans la prévention ?\nComment impliquer les patients dans la prévention ?\nQuels outils technologiques aident à la prévention ?\nQuelle est l'importance de la culture organisationnelle ?", "url": "https://questionsmedicales.fr/mesh/D028743?mesh_terms=Sample+Size&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Inconduite professionnelle", "description": "Quels traitements pour les victimes d'inconduite ?\nComment traiter l'inconduite chez un professionnel ?\nQuelles sanctions pour inconduite professionnelle ?\nComment réhabiliter un professionnel fautif ?\nQuels programmes de prévention existent ?", "url": "https://questionsmedicales.fr/mesh/D028743?mesh_terms=Sample+Size&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Inconduite professionnelle", "description": "Quelles complications peuvent résulter de l'inconduite ?\nComment l'inconduite affecte-t-elle la réputation ?\nY a-t-il des conséquences légales ?\nComment l'inconduite impacte-t-elle le personnel ?\nQuelles sont les répercussions sur les patients ?", "url": "https://questionsmedicales.fr/mesh/D028743?mesh_terms=Sample+Size&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Inconduite professionnelle", "description": "Quels facteurs augmentent le risque d'inconduite ?\nComment la formation influence-t-elle le risque ?\nQuel rôle joue l'environnement de travail ?\nLes antécédents personnels influencent-ils le risque ?\nComment la culture institutionnelle impacte-t-elle le risque ?", "url": "https://questionsmedicales.fr/mesh/D028743?mesh_terms=Sample+Size&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier l'inconduite professionnelle ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'inconduite se détecte par des plaintes, des comportements inappropriés ou des violations éthiques." } }, { "@type": "Question", "name": "Quels signes indiquent une inconduite ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des comportements tels que négligence, abus de pouvoir ou fraude peuvent indiquer une inconduite." } }, { "@type": "Question", "name": "Qui peut signaler une inconduite ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Tout membre du personnel médical, patient ou tiers peut signaler une inconduite professionnelle." } }, { "@type": "Question", "name": "Quels outils aident au diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des enquêtes, des audits et des évaluations de performance aident à diagnostiquer l'inconduite." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'un diagnostic tardif ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic tardif peut aggraver les dommages aux patients et compromettre la sécurité des soins." } }, { "@type": "Question", "name": "Quels symptômes peuvent alerter sur une inconduite ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des plaintes répétées de patients, des erreurs fréquentes ou un comportement inapproprié sont des symptômes." } }, { "@type": "Question", "name": "Comment les patients réagissent-ils à l'inconduite ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les patients peuvent ressentir de la méfiance, de l'anxiété ou de la détresse face à l'inconduite." } }, { "@type": "Question", "name": "Quels effets psychologiques l'inconduite a-t-elle ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "L'inconduite peut entraîner des traumatismes psychologiques chez les patients affectés." } }, { "@type": "Question", "name": "Y a-t-il des signes de stress chez le professionnel ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Un professionnel en inconduite peut montrer des signes de stress, d'irritabilité ou d'isolement." } }, { "@type": "Question", "name": "Comment l'inconduite affecte-t-elle l'équipe médicale ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut créer des tensions, diminuer la confiance et affecter la collaboration au sein de l'équipe." } }, { "@type": "Question", "name": "Comment prévenir l'inconduite professionnelle ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par des formations éthiques, des codes de conduite et un environnement de travail sain." } }, { "@type": "Question", "name": "Quel rôle joue la supervision dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une supervision adéquate permet de détecter et de corriger les comportements inappropriés rapidement." } }, { "@type": "Question", "name": "Comment impliquer les patients dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les patients peuvent être formés à reconnaître et signaler des comportements inappropriés." } }, { "@type": "Question", "name": "Quels outils technologiques aident à la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des systèmes de signalement en ligne et des applications de suivi des comportements peuvent aider." } }, { "@type": "Question", "name": "Quelle est l'importance de la culture organisationnelle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une culture organisationnelle positive favorise l'éthique et réduit les risques d'inconduite." } }, { "@type": "Question", "name": "Quels traitements pour les victimes d'inconduite ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les victimes peuvent bénéficier de thérapies psychologiques et de soutien émotionnel." } }, { "@type": "Question", "name": "Comment traiter l'inconduite chez un professionnel ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des mesures disciplinaires, des formations et un suivi psychologique peuvent être nécessaires." } }, { "@type": "Question", "name": "Quelles sanctions pour inconduite professionnelle ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les sanctions peuvent inclure des avertissements, des suspensions ou des radiations de l'ordre." } }, { "@type": "Question", "name": "Comment réhabiliter un professionnel fautif ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La réhabilitation peut passer par des formations, du mentorat et un suivi régulier." } }, { "@type": "Question", "name": "Quels programmes de prévention existent ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes de formation éthique et de sensibilisation sont mis en place pour prévenir l'inconduite." } }, { "@type": "Question", "name": "Quelles complications peuvent résulter de l'inconduite ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des dommages physiques, psychologiques et une perte de confiance dans le système de santé." } }, { "@type": "Question", "name": "Comment l'inconduite affecte-t-elle la réputation ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "L'inconduite peut gravement nuire à la réputation du professionnel et de l'établissement de santé." } }, { "@type": "Question", "name": "Y a-t-il des conséquences légales ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inconduite peut entraîner des poursuites judiciaires et des sanctions pénales." } }, { "@type": "Question", "name": "Comment l'inconduite impacte-t-elle le personnel ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut créer un environnement de travail toxique, affectant le moral et la productivité du personnel." } }, { "@type": "Question", "name": "Quelles sont les répercussions sur les patients ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les patients peuvent subir des erreurs médicales, des abus ou une détérioration de leur état de santé." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'inconduite ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le stress, la surcharge de travail et un manque de supervision sont des facteurs de risque importants." } }, { "@type": "Question", "name": "Comment la formation influence-t-elle le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Une formation insuffisante peut accroître le risque d'inconduite en diminuant la sensibilisation éthique." } }, { "@type": "Question", "name": "Quel rôle joue l'environnement de travail ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement de travail toxique ou compétitif peut favoriser l'inconduite professionnelle." } }, { "@type": "Question", "name": "Les antécédents personnels influencent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de comportements inappropriés ou de problèmes psychologiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Comment la culture institutionnelle impacte-t-elle le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Une culture institutionnelle laxiste envers l'éthique peut accroître le risque d'inconduite." } } ] } ] }

Sources (10000 au total)

Sample size recalculation based on the prevalence in a randomized test-treatment study.

Randomized test-treatment studies aim to evaluate the clinical utility of diagnostic tests by providing evidence on their impact on patient health. However, the sample size calculation is affected by ... An adaptive design with a blinded sample size recalculation in a randomized test-treatment study based on the prevalence is proposed and evaluated by a simulation study. The results of the adaptive de... The adaptive design achieves the desired theoretical power, under the assumption that all other nuisance parameters have been specified correctly, while wrong assumptions regarding the prevalence may ... The consideration of a blinded recalculation of the sample size already during the planning of the study may be advisable in order to increase the possibility of success as well as an enhanced process...

Sample size recalculation in three-stage clinical trials and its evaluation.

In clinical trials, the determination of an adequate sample size is a challenging task, mainly due to the uncertainty about the value of the effect size and nuisance parameters. One method to deal wit... In our research, we address sample size recalculation in three-stage trials, i.e. trials with two pre-planned interim analyses. We show how recalculation rules from two-stage trials can be modified to... While we observe a notable favorable effect in terms of power and expected sample size by using three-stage designs compared to two-stage designs, the benefits of recalculation rules appear less clear... Sample size recalculation is also applicable in three-stage designs. However, the extent to which recalculation brings benefits depends on which trial characteristics are most important to the applica...

Required sample size to detect mediation in 3-level implementation studies.

Statistical tests of mediation are important for advancing implementation science; however, little research has examined the sample sizes needed to detect mediation in 3-level designs (e.g., organizat... Statistical power was estimated for 17,496 3-level mediation designs in which the independent variable (X) resided at the highest cluster level (e.g., organization), the mediator (M) resided at the in... For 2-sided tests, statistical power to detect mediation was sufficient (≥0.8) in only 463 designs (2.6%) estimated using MVM and 228 designs (1.3%) estimated using MSEM; the minimum number of highest... While our analysis has important limitations, results suggest many of the 3-level mediation designs that can realistically be conducted in implementation research lack statistical power to detect medi...

Sample size calculation for prevalence studies using Scalex and ScalaR calculators.

Although books and articles guiding the methods of sample size calculation for prevalence studies are available, we aim to guide, assist and report sample size calculation using the present calculator... We present and discuss four parameters (namely level of confidence, precision, variability of the data, and anticipated loss) required for sample size calculation for prevalence studies. Choosing corr... Two calculators can be used with free software (Spreadsheet and RStudio) that benefit researchers with limited resources. It will, hopefully, minimize the errors in parameter selection, calculation, a...